The SURMOUNT-2 trial (N=938) demonstrated that tirzepatide 15 mg produced a mean A1C reduction of 2.1% and 14.7% body weight loss in adults with both obesity and type 2 diabetes over 72 weeks, data that can support an override request when dual benefit is clinically warranted [6]
However, the same mechanisms that slow gastric emptying and alter gastrointestinal motility can lead to digestive side effects, including constipation, which affects a notable proportion of users
Well, what I've noticed as one of the most profound You know, outcomes of my analysis of my patients is these people, these people's disordered eating is healing
In: IDF DIABETES ATLAS [Internet], 10th edition 2021
In cosmetic formulas, it tightens and firms loose skin, minimizes fine lines and wrinkles, reduces sun damage and discoloration, and boosts skin cell growth for a more youthful, radiant look
For the most up-to-date list of ingredients, please check the Patient Information Leaflet inside the box